Estrogen Exposure and Atherosclerosis in Postmenopausal Women
NCT ID: NCT02951949
Last Updated: 2020-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
92 participants
OBSERVATIONAL
2014-11-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
NCT02042196
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000549
Menopause Effects on Vascular Function
NCT03236545
Chronic Effects of Estrogen in Microcirculation
NCT01295892
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
NCT02122198
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Postmenopausal women
Postmenopausal women attending the outpatient service of a third level hospital for health control.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
45 Years
85 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Valencia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Cano Sanchez
Full Professor Obstetrics and Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Cano, MD
Role: PRINCIPAL_INVESTIGATOR
University of Valencia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clínico Universitario
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ayudas Fundación Eresa 2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.